Page 1 | Search Results | Blood | American Society of Hematology

Skip to Main Content

Skip Nav Destination

1-2 of 2

Sort by

Sort Order Select

Journal Articles

Phase 1/2 Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, and Efficacy of Marzeptacog Alfa (activated) in the Treatment of Episodic Bleeding in Subjects with Inherited Bleeding Disorders

Linda Neuman, MD, Shraddha Desai, PhD MS, Frank Del Greco, MBA, Tom Knudsen, PhD DVM, Howard Levy, PhD MBBChir

Blood (2020) 136 (Supplement 1): 32–33.

https://doi.org/10.1182/blood-2020-137223

Published: 2020

Journal Articles

The Crimson 1 Study: A Phase 3 Study to Evaluate the Efficacy and Safety of Subcutaneous Marzeptocog Alfa (activated) for on-Demand Treatment and Control of Bleeding Episodes in Subjects with Hemophilia A or Hemophilia B, with Inhibitors

Linda Neuman, MD, Shraddha Desai, PhD MS, Tom Knudsen, PhD DVM, Frank Del Greco, MBA, Howard Levy, PhD MBBChir

Blood (2020) 136 (Supplement 1): 39–40.

https://doi.org/10.1182/blood-2020-137806

Published: 2020